SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-20-013033
Filing Date
2020-11-06
Accepted
2020-11-06 09:29:35
Documents
14
Period of Report
2020-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K glyc-20201106x8k.htm   iXBRL 8-K 44185
2 EX-99.1 glyc-20201106xex99d1.htm EX-99.1 163322
3 GRAPHIC glyc-20201106xex99d1001.jpg GRAPHIC 7194
  Complete submission text file 0001558370-20-013033.txt   350153

Data Files

Seq Description Document Type Size
4 EX-101.SCH glyc-20201106.xsd EX-101.SCH 3224
5 EX-101.LAB glyc-20201106_lab.xml EX-101.LAB 15499
6 EX-101.PRE glyc-20201106_pre.xml EX-101.PRE 10518
7 EXTRACTED XBRL INSTANCE DOCUMENT glyc-20201106x8k_htm.xml XML 4664
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36177 | Film No.: 201292709
SIC: 2834 Pharmaceutical Preparations